Best TWAS P=4.05e-15 · Best GWAS P=1.39e-21 conditioned to 0.169
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | HECTD4 | 0.06 | 0.00 | enet | 15 | 0.02 | 1.0e-02 | 3.3 | -6.1 | 8.0e-10 | 0.65 | 0.06 | 0.84 | FALSE |
2 | GTEx | Adrenal Gland | PPTC7 | 0.13 | -0.01 | lasso | 6 | 0.00 | 3.4e-01 | 4.8 | 5.8 | 6.6e-09 | -0.26 | 0.03 | 0.15 | FALSE |
3 | GTEx | Artery Tibial | VPS29 | 0.05 | 0.03 | lasso | 3 | 0.02 | 5.9e-03 | 5.5 | 5.5 | 2.9e-08 | -0.11 | 0.02 | 0.90 | FALSE |
4 | GTEx | Artery Tibial | HECTD4 | 0.05 | 0.02 | lasso | 3 | 0.01 | 3.1e-02 | -8.4 | -7.8 | 4.0e-15 | 0.78 | 0.02 | 0.92 | TRUE |
5 | GTEx | Breast Mammary Tissue (Female) | VPS29 | 0.10 | -0.01 | lasso | 2 | 0.02 | 1.0e-01 | -4.6 | 5.9 | 3.2e-09 | -0.34 | 0.03 | 0.22 | TRUE |
6 | GTEx | Cells Transformed fibroblasts | VPS29 | 0.09 | 0.13 | lasso | 3 | 0.13 | 9.8e-10 | 5.5 | 5.2 | 2.2e-07 | -0.09 | 0.01 | 0.99 | FALSE |
7 | GTEx | Colon Transverse | FAM109A | 0.21 | 0.00 | lasso | 4 | 0.01 | 1.3e-01 | 5.1 | -6.0 | 1.6e-09 | 0.41 | 0.06 | 0.06 | FALSE |
8 | GTEx | Muscle Skeletal | VPS29 | 0.06 | 0.06 | lasso | 3 | 0.05 | 4.3e-06 | 5.5 | 5.4 | 8.4e-08 | -0.09 | 0.01 | 0.98 | FALSE |
9 | GTEx | Nerve Tibial | HECTD4 | 0.05 | 0.01 | enet | 6 | 0.01 | 3.6e-02 | 5.7 | -5.8 | 8.7e-09 | 0.41 | 0.22 | 0.46 | FALSE |
10 | GTEx | Skin Not Sun Exposed Suprapubic | VPS29 | 0.06 | 0.01 | lasso | 3 | 0.01 | 6.9e-02 | 4.8 | 5.4 | 7.6e-08 | -0.07 | 0.06 | 0.50 | FALSE |
11 | GTEx | Skin Sun Exposed Lower leg | ALDH2 | 0.10 | 0.09 | enet | 13 | 0.13 | 6.7e-11 | 3.0 | -6.1 | 1.3e-09 | 0.62 | 0.89 | 0.11 | FALSE |
12 | GTEx | Thyroid | BRAP | 0.07 | 0.02 | lasso | 7 | 0.03 | 1.1e-03 | 3.2 | 5.2 | 1.9e-07 | -0.54 | 0.34 | 0.46 | FALSE |
13 | GTEx | Thyroid | VPS29 | 0.07 | 0.01 | lasso | 5 | 0.01 | 8.9e-02 | 4.9 | 5.6 | 1.7e-08 | -0.11 | 0.03 | 0.76 | FALSE |
14 | NTR | Blood | ALDH2 | 0.06 | 0.01 | blup | 222 | 0.02 | 4.3e-08 | 4.2 | 6.2 | 4.5e-10 | -0.43 | 0.91 | 0.08 | FALSE |
15 | NTR | Blood | GPN3 | 0.03 | 0.01 | blup | 236 | 0.02 | 2.7e-06 | 4.5 | -5.4 | 6.6e-08 | 0.12 | 0.12 | 0.87 | FALSE |
16 | NTR | Blood | UBE3B | 0.09 | 0.05 | lasso | 8 | 0.08 | 1.0e-25 | 4.6 | 5.4 | 7.6e-08 | 0.04 | 0.24 | 0.75 | TRUE |
17 | YFS | Blood | GLTP | 0.05 | 0.01 | enet | 14 | 0.04 | 1.5e-13 | 3.7 | 5.1 | 3.0e-07 | -0.08 | 0.55 | 0.44 | FALSE |
18 | YFS | Blood | SH2B3 | 0.05 | 0.01 | enet | 22 | 0.02 | 3.3e-07 | 3.2 | -5.9 | 4.7e-09 | 0.64 | 0.66 | 0.34 | FALSE |
19 | YFS | Blood | TRAFD1 | 0.04 | 0.02 | lasso | 2 | 0.01 | 2.9e-05 | -4.2 | -5.3 | 8.6e-08 | 0.55 | 0.09 | 0.85 | FALSE |
20 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | KCTD10 | 0.06 | 0.00 | lasso | 3 | 0.00 | 1.4e-01 | 4.6 | -5.4 | 8.0e-08 | -0.05 | 0.00 | 0.33 | FALSE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | VPS29 | 0.02 | 0.02 | lasso | 5 | 0.03 | 4.6e-06 | 4.9 | 5.2 | 1.6e-07 | -0.07 | 0.00 | 0.99 | FALSE |
22 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ACAD10 | 0.02 | 0.02 | lasso | 3 | 0.01 | 7.0e-03 | 5.8 | 5.7 | 9.3e-09 | -0.50 | 0.01 | 0.91 | FALSE |
23 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | ERP29 | 0.11 | 0.03 | blup | 25 | 0.05 | 5.0e-03 | 3.2 | 5.1 | 3.1e-07 | -0.60 | 0.01 | 0.75 | FALSE |
24 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CUX2 | 0.08 | 0.01 | blup | 95 | 0.02 | 1.3e-03 | 4.7 | 6.6 | 4.0e-11 | -0.15 | 0.04 | 0.80 | TRUE |
25 | The Cancer Genome Atlas | Prostate Adenocarcinoma | MMAB | 0.06 | 0.06 | blup | 57 | 0.06 | 5.4e-07 | -4.2 | -5.2 | 1.9e-07 | -0.06 | 0.57 | 0.42 | FALSE |